Hepatitis A Vaccine
Hepatitis A vaccine does not affect course of HIV
Published in Hepatitis Weekly, June 2nd, 2003
"The safety and immunogenicity of inactivated hepatitis A (HepA) vaccine was assessed in 133 hepatitis A virus-seronegative, human immunodeficiency virus (HIV)-infected adults," scientists in the United States report.
"Patients were randomly assigned to receive, in a blinded fashion, either two doses of vaccine (1,440 enzyme-linked immunosorbent assay units) or placebo six months apart," said Carol A. Kemper and collaborators at Stanford University, the University of California-San Diego, University of Pennsylvania, and GlaxoSmithKline Biologicals....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-06-02)
More Articles from Hepatitis Weekly
- Autoimmune Hepatitis
Recurrent hepatitis can remain undetected after liver transplantation - Liver Failure
Livers rejected for transplantation still yield useful cells for therapy - Immunology
Counteracting loops explain immune response to hepatitis C virus infection - Liver Disease
Regular, light alcohol consumption stems toxin-induced acute hepatitis in rats - Occupational Health
Vinyl chloride monomer exposure compounds the effects of hepatitis B virus - Oncogenesis
Hepatitis C virus-related liver cancer can prevail where hepatitis B is endemic - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
